Works by Sattar, Naveed

Results: 592
    1
    2
    3
    4
    5
    6
    7

    The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 23, p. 5656, doi. 10.3390/jcm10235656
    By:
    • Studziński, Krzysztof;
    • Tomasik, Tomasz;
    • Windak, Adam;
    • Banach, Maciej;
    • Wójtowicz, Ewa;
    • Mastej, Mirosław;
    • Tomaszewski, Maciej;
    • Mikhailidis, Dimitri P.;
    • Toth, Peter P.;
    • Catapano, Alberico;
    • Ray, Kausik K.;
    • Howard, George;
    • Lip, Gregory Y.H.;
    • Charchar, Fadi J.;
    • Sattar, Naveed;
    • Williams, Bryan;
    • MacDonald, Thomas M.;
    • Penson, Peter E.;
    • Jóźwiak, Jacek J.
    Publication type:
    Article
    8

    Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 19, p. 4472, doi. 10.3390/jcm10194472
    By:
    • Labuz-Roszak, Beata;
    • Banach, Maciej;
    • Skrzypek, Michal;
    • Windak, Adam;
    • Tomasik, Tomasz;
    • Mastej, Miroslaw;
    • Tomaszewski, Maciej;
    • Mikhailidis, Dimitri P.;
    • Toth, Peter P.;
    • Catapano, Alberico;
    • Ray, Kausik K.;
    • Howard, George;
    • Lip, Gregory Y. H.;
    • Charchar, Fadi J.;
    • Sattar, Naveed;
    • Williams, Bryan;
    • MacDonald, Thomas M.;
    • Penson, Peter;
    • Jozwiak, Jacek J.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16

    Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2229, doi. 10.1111/dom.15531
    By:
    • Helmink, Marga A. G.;
    • Hageman, Steven H. J.;
    • Eliasson, Björn;
    • Sattar, Naveed;
    • Visseren, Frank L. J.;
    • Dorresteijn, Jannick A. N.;
    • Harris, Katie;
    • Peters, Sanne A. E.;
    • Woodward, Mark;
    • Szentkúti, Péter;
    • Højlund, Kurt;
    • Henriksen, Jan Erik;
    • Sørensen, Henrik Toft;
    • Serné, Erik H.;
    • van Sloten, Thomas T.;
    • Thomsen, Reimar W.;
    • Westerink, Jan
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA‐REG OUTCOME trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2775, doi. 10.1111/dom.14535
    By:
    • Vaduganathan, Muthiah;
    • Inzucchi, Silvio E.;
    • Sattar, Naveed;
    • Fitchett, David H.;
    • Ofstad, Anne Pernille;
    • Brueckmann, Martina;
    • George, Jyothis T.;
    • Verma, Subodh;
    • Mattheus, Michaela;
    • Wanner, Christoph;
    • Zinman, Bernard;
    • Butler, Javed
    Publication type:
    Article
    25
    26
    27

    Metformin and carotid intima‐media thickness in never‐smokers with type 1 diabetes: The REMOVAL trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1371, doi. 10.1111/dom.14350
    By:
    • Timmons, Joseph G.;
    • Greenlaw, Nicola;
    • Boyle, James G.;
    • Chaturvedi, Nish;
    • Ford, Ian;
    • Brouwers, Martijn C. G. J.;
    • Tillin, Therese;
    • Hramiak, Irene;
    • Hughes, Alun D.;
    • Jenkins, Alicia J.;
    • Klein, Barbara E. K.;
    • Klein, Ron;
    • Ooi, Teik C.;
    • Rossing, Peter;
    • Stehouwer, Coen D. A.;
    • Sattar, Naveed;
    • Colhoun, Helen M.;
    • Petrie, John R.
    Publication type:
    Article
    28

    Weight loss‐induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT).

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 711, doi. 10.1111/dom.14274
    By:
    • Thom, George;
    • McIntosh, Alasdair;
    • Messow, Claudia‐Martina;
    • Leslie, Wilma S.;
    • Barnes, Alison C.;
    • Brosnahan, Naomi;
    • McCombie, Louise;
    • Malkova, Dalia;
    • Al‐Mrabeh, Ahmad;
    • Zhyzhneuskaya, Sviatlana;
    • Welsh, Paul;
    • Sattar, Naveed;
    • Taylor, Roy;
    • Lean, Michael E. J.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions ( REMOVAL): An international multicentre trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 509, doi. 10.1111/dom.12840
    By:
    • Petrie, John R.;
    • Chaturvedi, Nish;
    • Ford, Ian;
    • Hramiak, Irene;
    • Hughes, Alun D.;
    • Jenkins, Alicia J.;
    • E. Klein, Barbara;
    • Klein, Ron;
    • Ooi, Teik Chye;
    • Rossing, Peter;
    • Sattar, Naveed;
    • Stehouwer, Coen D. A.;
    • Colhoun, Helen M.;
    • Ford, I;
    • Kean, S;
    • Thomson, E;
    • Gillespie, L;
    • Gibb, J;
    • Greenlaw, N;
    • Hramiak, I
    Publication type:
    Article
    35
    36

    Adiposity and cardiovascular outcomes in three‐year‐old children of participants in UPBEAT, an RCT of a complex intervention in pregnant women with obesity.

    Published in:
    Pediatric Obesity, 2021, v. 16, n. 3, p. 1, doi. 10.1111/ijpo.12725
    By:
    • Dalrymple, Kathryn V.;
    • Tydeman, Florence A. S.;
    • Taylor, Paul D.;
    • Flynn, Angela C.;
    • O'Keeffe, Majella;
    • Briley, Annette L.;
    • Santosh, Paramala;
    • Hayes, Louise;
    • Robson, Stephen C.;
    • Nelson, Scott M.;
    • Sattar, Naveed;
    • Whitworth, Melissa K.;
    • Mills, Harriet L.;
    • Singh, Claire;
    • Seed CStat, Paul T.;
    • White, Sara L.;
    • Lawlor, Deborah A.;
    • Godfrey, Keith M.;
    • Poston, Lucilla
    Publication type:
    Article
    37
    38
    39

    Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004–2015 studies.

    Published in:
    European Journal of Preventive Cardiology, 2023, v. 30, n. 12, p. 1195, doi. 10.1093/eurjpc/zwad101
    By:
    • Osadnik, Kamila;
    • Osadnik, Tadeusz;
    • Gierlotka, Marek;
    • Windak, Adam;
    • Tomasik, Tomasz;
    • Mastej, Mirosław;
    • Kuras, Agnieszka;
    • Jóźwiak, Kacper;
    • Penson, Peter E;
    • Lip, Gregory Y H;
    • Mikhailidis, Dimitri P;
    • Toth, Peter P;
    • Catapano, Alberico L;
    • Ray, Kausik K;
    • Howard, George;
    • Tomaszewski, Maciej;
    • Charchar, Fadi J;
    • Sattar, Naveed;
    • Williams, Bryan;
    • MacDonald, Thomas M
    Publication type:
    Article
    40

    Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).

    Published in:
    European Journal of Preventive Cardiology, 2023, v. 30, n. 1, p. 61, doi. 10.1093/eurjpc/zwac232
    By:
    • Østergaard, Helena Bleken;
    • Hageman, Steven H J;
    • Read, Stephanie H;
    • Taylor, Owen;
    • Pennells, Lisa;
    • Kaptoge, Stephen;
    • Petitjean, Carmen;
    • Xu, Zhe;
    • Shi, Fanchao;
    • McEvoy, John William;
    • Herrington, William;
    • Visseren, Frank L J;
    • Wood, Angela;
    • Eliasson, Björn;
    • Sattar, Naveed;
    • Wild, Sarah;
    • Angelantonio, Emanuele Di;
    • Dorresteijn, Jannick A N
    Publication type:
    Article
    41
    42

    Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions.

    Published in:
    European Journal of Preventive Cardiology, 2021, v. 28, n. 18, p. 1991, doi. 10.1093/eurjpc/zwaa063
    By:
    • Welsh, Paul;
    • Welsh, Claire;
    • Celis-Morales, Carlos A;
    • Brown, Rosemary;
    • Ho, Frederick K;
    • Ferguson, Lyn D;
    • Mark, Patrick B;
    • Lewsey, James;
    • Gray, Stuart R;
    • Lyall, Donald M;
    • Gill, Jason M R;
    • Pell, Jill P;
    • Lemos, James A de;
    • Willeit, Peter;
    • Sattar, Naveed
    Publication type:
    Article
    43

    Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions.

    Published in:
    European Journal of Preventive Cardiology, 2021, v. 28, n. 15, p. 1991, doi. 10.1093/eurjpc/zwaa063
    By:
    • Welsh, Paul;
    • Welsh, Claire;
    • Celis-Morales, Carlos A;
    • Brown, Rosemary;
    • Ho, Frederick K;
    • Ferguson, Lyn D;
    • Mark, Patrick B;
    • Lewsey, James;
    • Gray, Stuart R;
    • Lyall, Donald M;
    • Gill, Jason M R;
    • Pell, Jill P;
    • Lemos, James A de;
    • Willeit, Peter;
    • Sattar, Naveed
    Publication type:
    Article
    44
    45

    Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology.

    Published in:
    European Journal of Preventive Cardiology, 2020, v. 27, n. 2, p. 181, doi. 10.1177/2047487319893035
    By:
    • Piepoli, Massimo F;
    • Abreu, Ana;
    • Albus, Christian;
    • Ambrosetti, Marco;
    • Brotons, Carlos;
    • Catapano, Alberico L;
    • Corra, Ugo;
    • Cosyns, Bernard;
    • Deaton, Christi;
    • Graham, Ian;
    • Hoes, Arno;
    • Lochen, Maja-Lisa;
    • Matrone, Benedetta;
    • Redon, Josep;
    • Sattar, Naveed;
    • Smulders, Yvo;
    • Tiberi, Monica
    Publication type:
    Article
    46
    47
    48

    Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptide.

    Published in:
    European Journal of Preventive Cardiology, 2016, v. 23, n. 10, p. 1104, doi. 10.1177/2047487315617908
    By:
    • Poortvliet, Rosalinde KE;
    • van Peet, Petra G;
    • de Craen, Anton JM;
    • Mertens, Bart JA;
    • Mooijaart, Simon P;
    • Wijsman, Liselotte W;
    • Drewes, Yvonne M;
    • Ford, Ian;
    • Sattar, Naveed;
    • Jukema, J Wouter;
    • Stott, David J;
    • de Ruijter, Wouter;
    • Gussekloo, Jacobijn
    Publication type:
    Article
    49
    50

    Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease—results of the Immune Metabolic Associations in Psoriatic Arthritis study.

    Published in:
    Rheumatology, 2022, v. 61, n. 3, p. 1026, doi. 10.1093/rheumatology/keab474
    By:
    • Ferguson, Lyn D;
    • Cathcart, Susanne;
    • Rimmer, Dominic;
    • Semple, Gary;
    • Brooksbank, Katriona;
    • Paterson, Caron;
    • Brown, Rosemary;
    • Harvie, John;
    • Gao, Xuan;
    • Radjenovic, Aleksandra;
    • Welsh, Paul;
    • McInnes, Iain B;
    • Sattar, Naveed;
    • Siebert, Stefan
    Publication type:
    Article